1. Home
  2. ALOT vs CNTX Comparison

ALOT vs CNTX Comparison

Compare ALOT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • CNTX
  • Stock Information
  • Founded
  • ALOT 1969
  • CNTX 2015
  • Country
  • ALOT United States
  • CNTX United States
  • Employees
  • ALOT N/A
  • CNTX N/A
  • Industry
  • ALOT Computer peripheral equipment
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALOT Technology
  • CNTX Health Care
  • Exchange
  • ALOT Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • ALOT 69.2M
  • CNTX 78.0M
  • IPO Year
  • ALOT N/A
  • CNTX 2021
  • Fundamental
  • Price
  • ALOT $11.72
  • CNTX $0.64
  • Analyst Decision
  • ALOT
  • CNTX Strong Buy
  • Analyst Count
  • ALOT 0
  • CNTX 5
  • Target Price
  • ALOT N/A
  • CNTX $5.50
  • AVG Volume (30 Days)
  • ALOT 24.0K
  • CNTX 286.6K
  • Earning Date
  • ALOT 06-05-2025
  • CNTX 08-06-2025
  • Dividend Yield
  • ALOT N/A
  • CNTX N/A
  • EPS Growth
  • ALOT N/A
  • CNTX N/A
  • EPS
  • ALOT N/A
  • CNTX N/A
  • Revenue
  • ALOT $156,030,000.00
  • CNTX N/A
  • Revenue This Year
  • ALOT N/A
  • CNTX N/A
  • Revenue Next Year
  • ALOT N/A
  • CNTX N/A
  • P/E Ratio
  • ALOT N/A
  • CNTX N/A
  • Revenue Growth
  • ALOT 7.14
  • CNTX N/A
  • 52 Week Low
  • ALOT $7.53
  • CNTX $0.49
  • 52 Week High
  • ALOT $17.24
  • CNTX $2.75
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 71.36
  • CNTX 49.95
  • Support Level
  • ALOT $10.29
  • CNTX $0.62
  • Resistance Level
  • ALOT $12.01
  • CNTX $0.70
  • Average True Range (ATR)
  • ALOT 0.69
  • CNTX 0.05
  • MACD
  • ALOT 0.23
  • CNTX 0.01
  • Stochastic Oscillator
  • ALOT 77.54
  • CNTX 59.29

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: